May 14, 2021 03:50 PM
Megalob, which is involved in efforts to launch an ayurvedic vaccine for Covid-19, has received Rs 300 crore in funding. The megalob, which is supported by the IIT Alumni Council (Alumni Council), is based in Mumbai. Has been working for some time on the preparation of two doses of Covid-19 vaccine based on Ayurvedic medical practices.
The vaccine is likely to be available in the next six months, said Ravi Sharma, president of the IIT Alumni Council. An attempt is being made to make this ayurvedic vaccine in two doses in the form of injection and oral / nasal drops. In the first phase, the vaccine will be given to IIT alumni.
The effort is being spearheaded by Dr Arindam Bose, a biotechnology expert from Connecticut, USA. He previously served as head of the vaccine manufacturing division at Pfizer. Dr. Santaram Kane, an alumnus of IIT Bombay, will head the injectable adjuvant, oral / nasal injection department.
Ayurvedic vaccine for Covid-19! Megalob is also seeking partnerships with various diagnostics companies and other technology companies. IIT Alumni is unique in being the largest alumni institution in the world. This includes alumni from 23 IITs.
The IIT Alumni Council-founded Megalab has secured a Rs 300-crore seed funding and is developing a two-dose Ayurveda-based coronavirus vaccine that can stop the spread of the deadly virus and prevent infection within a few days of the first dose.
The Mumbai-based Megalab, set up last April by the council to drive the fight against the pandemic with ideas and money, will also be importing available vaccines from the West to be distributed first in Mumbai and then elsewhere, the alumni council president Ravi Sharma told on Thursday.